|
AU3130100A
|
|
LHRH antagonist peptides
|
|
US7083979B1
|
|
Methods for enhanced retroviral-mediated gene transfer
|
|
US6455499B1
|
|
Methods for treating disorders associated with LHRH activity
|
|
US6015671A
|
|
Myocardial grafts and cellular compositions
|
|
US6103692A
|
|
Inhibiting protein interactions
|
|
US5932432A
|
|
Expression library screen by prenylation of expressed proteins
|
|
AU1468797A
|
|
Ghrh-rp compositions and methods
|
|
US5779949A
|
|
Conversion of lead-contaminated soil into ceramic products
|
|
US5649911A
|
|
Intravenous catheter and delivery system
|
|
US5679701A
|
|
Derivatives of ryanodine and dehydroryanodine
|
|
WO9629348A1
|
|
Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases
|
|
AU4980596A
|
|
Intelligent remote visual monitoring system for home health care service
|
|
US5728115A
|
|
Perfusion clamp
|
|
AU4413096A
|
|
Phenylalanine free proteins
|
|
US6033907A
|
|
Enhanced virus-mediated DNA transfer
|
|
WO9609173A1
|
|
Novel colorant for use in business recording
|
|
US5797870A
|
|
Pericardial delivery of therapeutic and diagnostic agents
|
|
US5744361A
|
|
Expansion of human hematopoietic progenitor cells in a liquid medium
|
|
US5618518A
|
|
Methods and compositions for use against dental calculus in domestic animals
|
|
WO9532283A1
|
|
Sequence-specific endonucleases, and preparation and use of same
|
